Vaxart (NASDAQ: VXRT) is working on a coronavirus vaccine candidate. Recently, Vaxart said its omicron-specific candidate and its original candidate both protected against the variant in preclinical tests. Of course, even if Vaxart is successful, the company will make it to market much later than bigger rivals.
Regardless of how long you've been investing in the stock market, this has been a challenging year. Since all three major U.S. indexes hit their respective record-closing highs between mid-November and the first week of January, two of them have fallen into a bear market -- the broad-based S&P 500 and technology-dependent Nasdaq Composite. Although a plunging stock market can be unnerving and tug on investor's emotions, double-digit percentage drawdowns in the major indexes are a perfectly normal part of the investing cycle.
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $204.50, marking a +1.93% move from the previous day.